Cost-effectiveness of diagnostic imaging work-up and treatment for patients with intermittent claudication in the Netherlands

European Journal of Vascular and Endovascular Surgery

Volumn 25, Issue 3, 2003, Pages 213-223

  Visser, K ^a   de Vries, S O ^b   Kitslaar, P J E H M ^c   van Engelshoven, J M A ^c   Hunink, M G M ^a,d  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Bypass surgery; Cost effectiveness; Digital subtraction angiography; Duplex ultrasound; Intermittent claudication; Magnetic resonance angiography; Percutaneous transluminal angioplasty

Indexed keywords

ADULT; ARTICLE; BYPASS SURGERY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC IMAGING; DIGITAL SUBTRACTION ANGIOGRAPHY; DOPPLER ECHOGRAPHY; HEALTH CARE COST; HUMAN; INTERMITTENT CLAUDICATION; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NETHERLANDS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROBABILITY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; TREATMENT OUTCOME; AGED; COLOR ULTRASOUND FLOWMETRY; COST OF ILLNESS; ECONOMICS; RADIOGRAPHY; STATISTICAL MODEL; VASCULAR SURGERY;

ADULT; AGED; ANGIOGRAPHY, DIGITAL SUBTRACTION; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DIAGNOSTIC IMAGING; HEALTH CARE COSTS; HUMANS; INTERMITTENT CLAUDICATION; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MARKOV CHAINS; MODELS, ECONOMIC; NETHERLANDS; QUALITY OF LIFE; ULTRASONOGRAPHY, DOPPLER, COLOR; VASCULAR SURGICAL PROCEDURES;

EID: 0037365602     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejvs.2002.1838     Document Type: Article

References (48)

1. DORMANDY JA, RUTHERFORD RB. Management of peripheral arterial disease (PAD). J Vasc Surg 2000; 31: 1-296.
2. EGGLIN TK, O'MOORE PV, FEINSTEIN AR, WALTMAN AC. Complications of peripheral arteriography: a new system to identify patients at increased risk. J Vasc Surg 1995; 22: 787-794.
3. HESSEL SJ, ADAMS DF, ABRAMS HL. Complications of angiography. Radiology 1981; 138: 273-281.
4. VISSER K, HUNINK MGM. Peripheral arterial disease: gadolinium-enhanced MR angiography versus color-guided duplex US - A meta-analysis. Radiology 2000; 216: 67-77.
5. BOSCH JL, HUNINK MG. Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease. Radiology 1997; 204(1): 87-96.
6. DE VRIES SO, HUNINK MG. Results of aortic bifurcation grafts for aortoiliac occlusive disease: a meta-analysis. J Vasc Surg 1997; 26(4): 558-569.
7. HUNINK MGM, WONG JB, DONALDSON MC, MEYEROVITZ MF, HARRINGTON DP. Patency results of percutaneous and surgical revascularization for femoropopliteal arterial disease. Med Decis Making 1994; 14: 71-81.
8. JANSEN RM, DE VRIES SO, CULLEN KA, DONALDSON MC, HUNINK MGM. Cost-identification analysis of revascularization procedures on patients with peripheral arterial occlusive disease. J Vasc Surg 1998; 28: 617-623.
9. EKROTH R, DAHLLOF AG, GUNDEVALL B, HOLM J, SCHERSTEN T. Physical training of patients with intermittent claudication: indications, methods, and results. Surgery 1978; 84: 640-663.
10. CARTER SA, HAMEL ER, PATERSON JM, SNOW CJ, MYMIN D. Walking ability and ankle systolic pressures: observations in patients with intermittent claudication in a short-term walking exercise program. J Vasc Surg 1989; 10: 642-649.
11. HIATT WR, REGENSTEINER JG, HARGARTEN ME, WOLFEL EE, BRASS EP. Benefit of exercise conditioning for patients with peripheral arterial disease. Circulation 1990; 81: 602-669.
12. RADACK K, WYDERSKI RJ. Conservative management of intermittent claudication. Ann Int Med 1990; 113: 135-146.
13. DE VRIES SO, VISSER K, DE VRIES JA, WONG JB, DONALDSON MC, HUNINK MGM. Intermittent claudication: cost-effectiveness of revascularization versus exercise therapy. Radiology 2002; 222: 25-36.
14. VISSER K, KUNTZ KM, DONALDSON MC, GAZELLE GS, HUNINK MGM. Pre-treatment imaging work-up for patients with intermittent claudication: a cost-effectiveness analysis. JVIR 2003, in press.
15. BAUM RA, RUTTER CM, SUNSHINE JH, BLEBEA JS, BLEBEA J, CARPENTER JP et al. Multicenter trial to evaluate vascular magnetic resonance angiography of the lower extremity. American College of Radiology Rapid Technology Assessment Group. JAMA 1995; 274: 875-880.
16. DORMANDY JA, RUTHERFORD RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Concensus (TASC). J Vasc Surg 2000; 31(1 Pt 2): S1-S296.
17. OOSTENBRINK JB, KOOPMANSCHAP MA, RUTTEN FFH. Handleiding voor kostenonderzoek, methoden en richtlijnprijzen voor economische evaluaties in de gezondheidszorg. Amstelveen: College voor zorgverzekeringen, 2000.
18. DRUMMOND MF, O'BRIEN B, STODDART GL, TORRANCE GW. Cost analysis. In: Drummond MF et al., eds. Methods for the Economic Evaluation of Health Care Programmes. Great Britain: Oxford University Press, 1997; 52-95.
19. VAN BERGEN PF, JONKER JJ, VAN HOUT BA, VAN DOMBURG RT, DECKERS JW, AZAR AJ et al. Costs and effects of long-term oral anticoagulant treatment after myocardial infarction. JAMA 1995; 273(12): 925-928.
20. PERNOT HF, WINNUBST GM, CLUITMANS JJ, DE WITTE LP. Amputees in Limburg: incidence, morbidity and mortality, prosthetic supply, care utilisation and functional level after one year. Prosthet Orthot Int 2000; 24(2): 90-96.
21. WAUGH JR, SACHARIAS N. Arteriographic complications in the DSA era. Radiology 1992; 182: 243-246.
22. QUINN SF, SHELEY RC, SEMONSEN KG, LEONARDO VJ, KOJIMA K, SZUMOWSKI J. Aortic and lower-extremity arterial disease: evaluation with MR angiography versus conventional angiography. Radiology 1998; 206: 693-701.
23. KOHLER TR, ANDROS G, PORTER JM, CLOWES A, GOLDSTONE J, JOHANSEN K et al. Can duplex scanning replace arteriography for lower extremity arterial disease? Ann Vasc Surg 1990; 4: 280-287.
24. ELSMAN BH, LEGEMATE DA, VAN DER HEIJDEN FH, DE VOS HJ, MALI WPTM, EIKELBOOM BC. Impact of ultrasonographic duplex scanning on therapeutic decision making in lower-limb arterial disease. Br J Surg 1995; 82: 630-633.
25. ASCHER E, MAZZARIOL F, HINGORANI A, SALLES-CUNHA S, GADE P. The use of duplex ultrasound arterial mapping as an alternative to conventional arteriography for primary and secondary infrapopliteal bypasses. Am J Surg 1999; 178: 162-165.
26. DE VRIES SO, FIDLER V, KUIPERS WD, HUNINK MG. Fitting multistate transition models with autoregressive logistic regression: supervised exercise in intermittent claudication. Med Decis Making 1998; 18(1): 52-60.
27. CBO. Centraal Begeleidingsorgaan voor Intercollegiale Toetsing. Consensus bijeenkomst: diagnostiek en behandeling van arteriële claudicatio intermittens, 1997.
28. Auditing surgical outcome. 10 Years with the Swedish Vascular Registry - Swedvasc. Eur J Surg Suppl 1998; 581: 1-48.
29. HUNINK MGM, WONG JB, DONALDSON MC, MEYEROVITZ MF, DE VRIES JA, HARRINGTON DP. Revascularization for femoro-popliteal disease. A decision and cost-effectiveness analysis. JAMA 1995; 274: 165-171.
30. PLECHA FR, BERTIN VJ, PLECH EJ, AVELLONE JC, FARRELL CJ, HERTZER NR et al. The early results of vascular surgery in patients 75 years of age and older: an analysis of 3259 cases. J Vasc Surg 1985; 2: 769-774.
31. WEISS GN, GORTON A, READ RC, NEAL LA. Outcomes of lower extremity amputations. J Am Geriatr Soc 1990; 38: 877-883.
32. DE VRIES SO, DONALDSON MC, HUNINK MG. Contralateral symptoms after unilateral intervention for peripheral occlusive disease. J Vasc Surg 1998; 27(3): 414-421.
33. BLOOR K. Natural history of arteriosclerosis of the lower extremities. Ann Roy Coll Surg Eng 1961; 28: 36-52.
34. ROSENBLOOM MS, FLANIGAN DP, SCHULER JJ, MEYER JP, DURHAM JR, ELDRUP-JORGENSEN J et al. Risk factors affecting the natural history of intermittent claudication. Arch Surg 1988; 123: 867-870.
35. JELNES R, GAARDSTING O, HOUGAARD JENSEN K, BAEKGAARD N, TONNESEN KH, SCHROEDER T. Fate in intermittent claudication: outcome and risk factors. Br Med J Clin Res Ed 1986; 293: 1137-1140.
36. JONASON T, RINGQVIST I. Factors of prognostic importance for subsequent rest pain in patients with intermittent claudication. Acta Med Scand 1985; 218(1): 27-33.
37. BEGG TB, RICHARDS RL. The prognosis of intermittent claudication. Scot Med J 1962; 7: 341-352.
38. JUERGENS JL, BARKER NW, HINES EA. Arteriosclerosis obliterans: review of 520 cases with special reference to pathogenic and prognostic factors. Circulation 1960; 21: 188-195.
39. KALLERO KS. Mortality and morbidity in patients with intermittent claudication as defined by venous occlusion plethysmography. A ten-year follow-up study. J Chron Dis 1981; 34: 455-462.
40. DE VRIES SO, KUIPERS WD, HUNINK MGM. Intermittent claudication: symptom severity versus health values. J Vasc Surg 1998; 27: 422-430.
41. SCULPHER M, MICHAELS J, MCKENNA M, MINOR J. A cost-utility analysis of laser-assisted angioplasty for peripheral arterial occlusions. Int J Technol Assess Health Care 1996; 12: 104-125.
42. TSEVAT J, GOLDMAN L, LAMAS GA, PFEFFER MA, CHAPIN CC, CONNORS KF et al. Functional status versus utilities in survivors of myocardial infarction. Med Care 1991; 29: 1153-1159.
43. GOLD MR, SIEGEL JE, RUSSELL LB, WEINSTEIN MC. Cost-Effectiveness in Health and Medicine. 1st edn. New York: Oxford University Press, 1996.
44. CARPENTER JP, OWEN RS, BAUM RA, COPE C, BARKER CF, BERKOWITZ HD et al. Magnetic resonance angiography of peripheral runoff vessels. J Vasc Surg 1992; 16: 807-813.
45. OWEN RS, CARPENTER JP, BAUM RA, PERLOFF LJ, COPE C. Magnetic resonance imaging of angiographically occult runoff vessels in peripheral arterial occlusive disease. N Engl J Med 1992; 326: 1577-1581.
46. GRAHAM JD, CORSO PS, MORRIS JM, SEGUI-GOMEZ M, WEINSTEIN MC. Evaluating the cost-effectiveness of clinical and public health measures. Annu Rev Public Health 1998; 19: 125-152.
47. VAN HOUT B, BONSEL G, HABBEMA D, VAN DER MAAS P, DE CHARRO F. Heart transplantation in the Netherlands; costs, effects and scenarios. J Health Econ 1993; 12(1): 73-93.
48. VAN ENCKEVORT PJ, TENVERGERT EM, BONSEL GJ, GEERTSMA A, VAN DER BIJ W, DE BOER WJ et al. Technology assessment of the Dutch Lung Transplantation Program. Int J Technol Assess Health Care 1998; 14(2): 344-356.